The 67th American Society of Hematology (ASH) Annual Meeting and Exposition took place 6-9 December 2025, in Orlando, Florida. Diana Turner rounds up the latest clinical trial data shared at the meeting.  Early-stage trials KLN-1010 for multiple myeloma Kelonia Therapeutics announced the first results from the ongoing inMMyCAR study, a Phase I clinical trial evaluating […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!